As Value Assessment Frameworks Evolve, Are They Finally Ready for Prime Time?

Dubois, Robert W; Westrich, Kimberly

Dubois, Robert W; Westrich, Kimberly.

Affiliation

Dubois RW; The National Pharmaceutical Council, Washington DC, USA. Electronic address: rdubois@npcnow.org.
Westrich K; The National Pharmaceutical Council, Washington DC, USA.

Value Health ; 22(9): 977-980, 2019 09.

Article in En | MEDLINE | ID: mdl-31511186

Subject(s)

Cost-Benefit Analysis/methods; Cost-Benefit Analysis/standards; Delivery of Health Care/economics; Budgets; Decision Making; Humans; Models, Economic; Patient Preference; Patient-Centered Care/economics; Reproducibility of Results; United States

Key words

cost-effectiveness; health spending; pharmaceuticals; value assessment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cost-Benefit Analysis / Delivery of Health Care Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: America do norte Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google